Expansion of the Time Window for IV tPA Treatment of Acute Ischemic Stroke

Updated:Jul 17,2014

Expansion of the Time Window for Treatment of Acute Ischemic Stroke With Intravenous Tissue Plasminogen Activator

  • Approximately 795,000 strokes occur in the United States each year; about 600,000 are ischemic.
  • Current guidelines recommend administration of tissue plasminogen activator (rtPA) for acute ischemic stroke within 3 hours of stroke symptom onset.
  • Recent results of the European Cooperative Acute Stroke Study (ECASS-3) show evidence of an expanded time window between 3.0 and 4.5 hours for persons experiencing acute ischemic stroke symptoms.

    Read full article in Stroke

Supporting Materials

 

 


Professional Online Network

Connect with over 30,000 heart and stroke professionals.